A0A2J8IYW7 (A0A2J8IYW7_PANTR) Pan troglodytes (Chimpanzee)
Tyrosine-protein kinase UniProtKBInterProInteractive Modelling
509 aa; Sequence (Fasta) ;
4 identical sequences: Homo sapiens: P06239, A0A0S2Z3Y8; Pan paniscus: A0A2R9AKH9; Gorilla gorilla gorilla: G3QJD4
It is possible new templates exist for this target since these models were created.
Available Structures
57 Experimental Structures
Description | PDB ID | Oligo-state | Range | Ligands | ||
---|---|---|---|---|---|---|
SH3-SH2 DOMAIN FRAGMENT OF HUMAN P56-LCK TYROSINE KINASE COMPLEXED WITH THE 10 RESIDUE SYNTHETIC PH… |
Heteromer P06239; | |||||
Assess | ||||||
Crystal Structure of Lck SH2-SH3 with SH2 binding site of p130Cas |
Heteromer P06239; Q63767; | 6×NA; | ||||
Assess | ||||||
Monobody Mb(Lck_3) bound to Lck-SH2 domain |
Heteromer P06239; | 2×ZN; | ||||
Assess | ||||||
SH2 (SRC HOMOLOGY-2) DOMAIN OF HUMAN P56-LCK TYROSINE KINASE COMPLEXED WITH THE 11 RESIDUE PHOSPHOT… |
Heteromer P03079; P06239; | |||||
Assess | ||||||
FREE P56LCK SH2 DOMAIN |
Heteromer P06239; | |||||
Assess | ||||||
Monobody Mb(Lck_1) bound to Lck-Sh2 |
Heteromer P06239; | 3×SO4; | ||||
Assess | ||||||
Solution structure of T-cell surface glycoprotein CD4 and Proto-oncogene tyrosine-protein kinase LC… |
Heteromer P01730; P06239; | 1×ZN; | ||||
Assess | ||||||
Solution structure of T-cell surface glycoprotein CD8 alpha chain and Proto-oncogene tyrosine-prote… |
Heteromer P01732; P06239; | 1×ZN; | ||||
Assess | ||||||
Protein Tyrosine Phosphatase PTPN-22 (Lyp) bound to the mono-Phosphorylated Lck active site peptide |
Heteromer P06239; Q9Y2R2; | 1×PO4; | ||||
Assess | ||||||
Crystal structure of UNC119 in complex with LCK peptide |
Heteromer P06239; Q13432; | 2×GOL; 1×15P; 1×MYR; | ||||
Assess | ||||||
crystal structure of aminoquinazoline 1 bound to Lck | homo-2-mer | 2×242; | ||||
Assess | ||||||
HUMAN P56LCK TYROSINE KINASE COMPLEXED WITH PHOSPHOPEPTIDE | homo-2-mer | |||||
Assess | ||||||
SH3 Domain of Human Lck | homo-2-mer | 2×ZN; 2×CA; 2×PG4; | ||||
Assess | ||||||
Tyrosine-protein kinase LCK bound to Compound 11 | monomer | 1×ODJ; 1×CXS; 2×SO4; 1×NI; | ||||
Assess | ||||||
Crystal structure of Triazolone derivative bound to the kinase domain of human LCK, (auto-phosphory… | monomer | 2×SO4; 1×DMS; 1×MPD; 1×5PB; | ||||
Assess | ||||||
x-ray crystal structure of 2-aminopyrimidine carbamate 43 bound to Lck | monomer | 1×SO4; 1×1N9; | ||||
Assess | ||||||
Crystal structure of Pyrazolo pyrimidine derivative bound to the kinase domain of human LCK, (auto-… | monomer | 2×SO4; 1×DMS; 1×KSC; | ||||
Assess | ||||||
STRUCTURAL ANALYSIS OF THE LYMPHOCYTE-SPECIFIC KINASE LCK IN COMPLEX WITH NON-SELECTIVE AND SRC FAM… | monomer | 3×SO4; 1×ANP; 1×EDO; | ||||
Assess | ||||||
Crystal structure of pyrazin derivative bound to the kinase domain of Human LCK, (Auto-phosphorylat… | monomer | 2×SO4; 1×DMS; 1×MPD; 1×KZI; | ||||
Assess | ||||||
X-ray co-crystal structure aminobenzimidazole triazine 1 bound to Lck | monomer | 2×SO4; 1×AM0; | ||||
Assess | ||||||
STRUCTURAL ANALYSIS OF THE LYMPHOCYTE-SPECIFIC KINASE LCK IN COMPLEX WITH NON-SELECTIVE AND SRC FAM… | monomer | 1×SO4; 1×STU; | ||||
Assess | ||||||
Crystal structure of pyrazolo pyrimidine derivative bound to the kinase domain of human LCK, (auto-… | monomer | 2×SO4; 1×DMS; 1×MPD; 1×KSE; | ||||
Assess | ||||||
Crystal structure of imidazo pyrimidine derivative bound to the kinase domain of human LCK, (Auto-p… | monomer | 2×SO4; 1×DMS; 1×KSS; | ||||
Assess | ||||||
co-crystal structure of Lck and aminopyrimidine amide 10b | monomer | 1×AM5; | ||||
Assess | ||||||
Crystal Structure of Methoxy Benzofuran Derivative bound to the Kinase domain of human LCK, (auto-p… | monomer | 2×SO4; 1×DMS; 1×MPD; 1×KBM; | ||||
Assess | ||||||
Crystal structure of triazolo pyrimidine derivative bound to the kinase domain of human LCK, (auto-… | monomer | 2×SO4; 1×DMS; 1×KZM; | ||||
Assess | ||||||
Crystal structure of pyrazolo pyrimidine derivative bound to the kinase domain of human LCK, (auto-… | monomer | 2×SO4; 1×KSH; | ||||
Assess | ||||||
Crystal structure of Pyrrolo pyrazine derivative bound to the kinase domain of human LCK, (auto-pho… | monomer | 2×SO4; 1×DMS; 1×KSR; | ||||
Assess | ||||||
Crystal structure of triazolo pyrimidine derivative bound to the kinase domain of human LCK, (auto-… | monomer | 2×SO4; 1×DMS; 1×KZL; | ||||
Assess | ||||||
THE KINASE DOMAIN OF HUMAN LYMPHOCYTE KINASE (LCK), ACTIVATED FORM (AUTO-PHOSPHORYLATED ON TYR394) | monomer | 1×SO4; | ||||
Assess | ||||||
STRUCTURAL ANALYSIS OF THE LYMPHOCYTE-SPECIFIC KINASE LCK IN COMPLEX WITH NON-SELECTIVE AND SRC FAM… | monomer | 3×SO4; 1×PP2; | ||||
Assess | ||||||
crystal structure of furanopyrimidine 8 bound to lck | monomer | 1×547; | ||||
Assess | ||||||
X-Ray co-crystal structure of 2-amino-6-phenylpyrimido[5',4':5,6]pyrimido[1,2-a]benzimidazol-5(6H)-… | monomer | 1×SO4; 1×AM9; | ||||
Assess | ||||||
Crystal structure of imidazo pyrazin 1 bound to the kinase domain of human LCK, (auto-phosphorylate… | monomer | 2×SO4; 1×DMS; 1×KSF; | ||||
Assess | ||||||
co-crystal structure of Lck and aminopyrimidine reverse amide 23 | monomer | 1×AM6; | ||||
Assess | ||||||
Crystal structure of pyrazolo pyrimidine derivative bound to the kinase domain of human LCK, (auto-… | monomer | 2×SO4; 1×KSK; | ||||
Assess | ||||||
Crystal structure of phenylimidazo pyrazin 2 bound to the kinase domain of human LCK, (auto-phospho… | monomer | 1×SO4; 1×KSL; | ||||
Assess | ||||||
crystal structure of furanopyrimidine 1 bound to lck | monomer | 1×979; | ||||
Assess | ||||||
Crystal structure of imidazo quinoxaline 1 bound to the kinase domain of human LCK, activated form … | monomer | 2×SO4; 1×DMS; 1×KSM; | ||||
Assess | ||||||
Structure of human LCK kinase with a small molecule inhibitor | monomer | 1×LHL; 1×SO4; | ||||
Assess | ||||||
LCK bound to imatinib | monomer | 1×STI; | ||||
Assess | ||||||
CRYSTAL STRUCTURE OF THE LYMPHOCYTE-SPECIFIC KINASE LCK IN COMPLEX WITH STAUROSPORINE. | monomer | 1×SO4; 1×STU; | ||||
Assess | ||||||
The complex crystal structure of LCK with a probe molecule w259 | monomer | 1×SO4; 1×CA; 1×925; | ||||
Assess | ||||||
Crystal structure of pyrimidine amide 11 bound to Lck | monomer | 1×9NH; | ||||
Assess | ||||||
crystal structure of aminoquinazoline 36 bound to Lck | monomer | 1×1N8; | ||||
Assess | ||||||
Structure of Lck in complex with a compound discovered by Virtual Fragment Linking | monomer | 1×7KW; | ||||
Assess | ||||||
LCK complexed with a pyrazolopyrimidine | monomer | 1×5LK; 1×EDO; | ||||
Assess | ||||||
Crystal structure of a SH3-SH2 domains of a lymphocyte-specific protein tyrosine kinase (LCK) from … | monomer | 1×SO4; 2×GOL; | ||||
Assess | ||||||
HUMAN P56-LCK TYROSINE KINASE SH2 DOMAIN IN COMPLEX WITH THE PHOSPHOTYROSYL PEPTIDE AC-PTYR-GLU-GLU… | monomer | 1×ACE; | ||||
Assess | ||||||
P56LCK SH2 DOMAIN INHIBITOR COMPLEX | monomer | |||||
Assess | ||||||
HUMAN P56-LCK TYROSINE KINASE SH2 DOMAIN IN COMPLEX WITH THE PHOSPHOTYROSYL PEPTIDE AC-PTYR-GLU-GLU… | monomer | |||||
Assess | ||||||
Crystal structure of LCK SH2 complexed with nonpeptide phosphotyrosine mimetic | monomer | 1×CC0; | ||||
Assess | ||||||
Structure-based design of a novel, osteoclast-selective, nonpeptide Src SH2 inhibitor with in vivo … | monomer | 1×CC1; | ||||
Assess | ||||||
The Crystal Structure of LCK from Biortus. | monomer | 1×CL; 1×EDO; 1×PG4; | ||||
Assess | ||||||
HUMAN P56LCK TYROSINE KINASE COMPLEXED WITH PHOSPHOPEPTIDE | monomer | |||||
Assess | ||||||
SH3 domain of human Lck tyrosine kinase | monomer | |||||
Assess | ||||||
SH3 Domain of Lymphocyte Specific Kinase (LCK) | monomer | |||||
Assess |
4 SWISS-MODEL models
Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
1y57.1.A | monomer | 0.79 | 60.59 | |||
Assess | ||||||
2h8h.1.A | monomer | 0.78 | 60.44 | |||
Assess | ||||||
1opl.2.A | monomer | 0.75 | 43.06 | |||
Assess | ||||||
8gmb.1.A | monomer | 0.71 | 35.85 | |||
Assess |